↓ Skip to main content

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, July 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
54 Mendeley
Title
Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer
Published in
Cancer Chemotherapy and Pharmacology, July 2012
DOI 10.1007/s00280-012-1916-9
Pubmed ID
Authors

A. W. Tolcher, K. N. Chi, N. D. Shore, R. Pili, A. Molina, M. Acharya, T. Kheoh, J. J. Jiao, M. Gonzalez, A. Trinh, C. Pankras, N. Tran

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 2%
Unknown 53 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 17%
Researcher 7 13%
Student > Ph. D. Student 6 11%
Student > Postgraduate 5 9%
Lecturer 4 7%
Other 15 28%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 18 33%
Agricultural and Biological Sciences 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Computer Science 3 6%
Engineering 2 4%
Other 8 15%
Unknown 13 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2013.
All research outputs
#8,092,839
of 24,287,598 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#696
of 2,522 outputs
Outputs of similar age
#56,718
of 167,164 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#9
of 22 outputs
Altmetric has tracked 24,287,598 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,522 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,164 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.